Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

MENU

ONC eNewsletter

ONC: Oncology News Connection from Fox Chase Cancer Center

A Fox Chase Cancer Center publication for physicians

Oncology News Connection: Winter 2021

Fox Chase Clinical Trial Program Adapts During the COVID-19 Pandemic

Pulsed Low-Dose-Rate Radiation Offers New Treatment Option for Variety of Solid Tumors

Fox Chase Offering Prostate Micro-Ultrasound Technology

CAR T-Cell Therapy Now Available at Fox Chase for Relapsed and Refractory Mantle Cell Lymphoma

International Collaboration Finds Ripretinib Significantly Improves Survival for Patients With Advanced Gastrointestinal Tumors

Oncology News Connection: Winter 2020

Fox Chase Researchers Actively Recruiting For Breast Cancer Immunotherapy Trials

PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer

Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care

Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment

Immunotherapy for Never Smokers with Non-Small Cell Lung Cancer

Identification and Management of Immunotherapy Toxicities

Oncology News Connection: Summer 2019

The Latest Cellular Immunotherapies Only Available at Certified Cancer Centers

Is Surgery Necessary for Melanoma with Sentinel Node Metastasis?

Delivering an Effective Radiation Dose to Liver Tumors

New Systemic Therapies for Advanced HCC

New Tool Rapidly Matches Patients to Clinical Trials Based on Patient-Specific Eligibility

Oncology News Connection: Winter 2019

De-escalating Treatment for Bladder and Prostate Cancers

The Fastest Growing Oncology Population

Men With Metastatic Prostate Cancer Need Genetic Testing

Retroperitoneal Sarcoma’s Radiation Therapy Options Are Expanding

Many Women With Early-Stage Breast Cancer Can Skip Chemotherapy